Abbott's Humira Ad Makes Unsupported Claims: FDA
The U.S. Food and Drug Administration has issued a warning to Abbott Laboratories, saying that an advertisement for the pharmaceutical company's arthritis and psoriasis treatment Humira is misleading and makes claims...To view the full article, register now.
Already a subscriber? Click here to view full article